top of page
![XEOMIN_landing_page_v1.jpg](https://static.wixstatic.com/media/60c4f2_923650656e224b74a77c6d8597c74f6e~mv2.jpg/v1/fill/w_980,h_345,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/60c4f2_923650656e224b74a77c6d8597c74f6e~mv2.jpg)
零雜質的純淨
零雜質 = 減少產生抗體的風險
新一代零雜質的純淨,不含複合蛋白的品牌。由於複合蛋白可能刺激人體產生抗體,一旦有抗藥性的產生,有可能會導致療程失效。因此,不含複合蛋白可減少抗藥性的風險,可以維持長期施打的安全性和有效性。
零雜質的純淨有什麼好處?
![](https://static.wixstatic.com/media/60c4f2_ab5c699d69bc4dca8cfe66bd1d803141~mv2.png/v1/fill/w_80,h_80,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/60c4f2_ab5c699d69bc4dca8cfe66bd1d803141~mv2.png)
Zero 零風險=減少產生安全隱患
![XEOMIN_landing_page_v1-03.png](https://static.wixstatic.com/media/60c4f2_c30ab9716aae47a2b49e2b093045eb64~mv2.png/v1/fill/w_80,h_80,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-03.png)
Efficacy 透過醫療臨床證實
![XEOMIN_landing_page_v1-04.png](https://static.wixstatic.com/media/60c4f2_993d44794abf41cf915a366dce3c677b~mv2.png/v1/fill/w_81,h_80,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-04.png)
Reduced 減低抗藥性的風險
![XEOMIN_landing_page_v1-05.png](https://static.wixstatic.com/media/60c4f2_ea1d2b4e0f6a404b9dcef71d25b4d7f6~mv2.png/v1/fill/w_80,h_80,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-05.png)
0ptimal 每次療程均達致理想效果
先進的雙重淨化技術
由德國Merz藥廠利用先進Double Purification雙重淨化技術提煉,除去所有雜質,只保留活性神經毒素以減低身體產生抗體的風險。是在監管嚴格的GMP藥廠環境內生產之唯一不含雜質的產品。
不含雜質
![XEOMIN_landing_page_v1-06.png](https://static.wixstatic.com/media/60c4f2_e1a809f67c07480ca8fab71c4242a931~mv2.png/v1/crop/x_1,y_0,w_398,h_160/fill/w_358,h_144,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-06.png)
![XEOMIN_landing_page_v1-07.png](https://static.wixstatic.com/media/60c4f2_8089ac9bd7464a76bcf58dd3097343cd~mv2.png/v1/crop/x_1,y_0,w_398,h_160/fill/w_358,h_144,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-07.png)
能有效消泡引致動態皺紋的神經細胞訊息傳遞功能,使引致動態皺紋的修剪得以鬆弛,令肌膚線條變得更光滑,並可防止新皺紋的形成
![XEOMIN_landing_page_v1-08.png](https://static.wixstatic.com/media/60c4f2_3cd71c447dab4014a12a505bf9654acf~mv2.png/v1/fill/w_599,h_413,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-08.png)
信心之選
-
產品已連續10年成為美國最熱門醫學美容療程。
-
唯一獲美國食品及藥物管理局(美國FDA)核准、英國UK MHRA及德國The Federal Institute for Drugs andMedical Device核准及香港衛生署注冊的產品。
-
已被全球超過四十個國家核准用於醫學美容上。
-
臨床研究顯示,長期使用是相當安全的,而療效亦不會因重覆接受療程而下降。
-
超過98%的使用者對療程表示有改善。
![XEOMIN_landing_page_v1-09.png](https://static.wixstatic.com/media/60c4f2_a99bc3b3cdf4425bb6aee7ce80ae8717~mv2.png/v1/fill/w_421,h_210,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-09.png)
![XEOMIN_landing_page_v1-10.png](https://static.wixstatic.com/media/60c4f2_1a527109982e46649514ede3cf939dfa~mv2.png/v1/fill/w_421,h_210,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-10.png)
![XEOMIN_landing_page_v1-11.png](https://static.wixstatic.com/media/60c4f2_b25ee8eaf60049cda4a0ff0349a65ae6~mv2.png/v1/fill/w_421,h_210,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-11.png)
![XEOMIN_landing_page_v1-12.png](https://static.wixstatic.com/media/60c4f2_cb6fd50107914c6ead108c6f488c877d~mv2.png/v1/fill/w_421,h_210,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/XEOMIN_landing_page_v1-12.png)
* 雜質 是指複合蛋白、非活躍神經毒素、鞭毛蛋白和細菌DNA。1,2
+ 純淨是指不含複合蛋白、非活躍神經毒素、鞭毛蛋白和細菌DNA。1,2
^ 與其他香港注冊品牌比較。1,2
1. Park JY et al. Neurotoxin impurities: A Review of threats to Efficacy. Plast Recontr Surg Glob Open. 2020:8(1)e2627
2. Kerscher M, et al. A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A. J Drugs Dermatol. 2019 Jan 1:18(1):52-57
3. Prager Wet al. Clin Intery Aging.2013; 8:449 456
4. Approved Product Information. Aug 2021.
5. American Society of Plastic Surgeons. (2015) Plastic Surgery Procedural Statistics 2004-2014. Retrieved November 18. 2016, from American Society of Plastic Surgeons.
http://www.plasticsurgery.org/news/plastic-surgery-statistics.html
6. Rzany B, et al. Long-term results for in the treatment of glabellar frown lines. . 2013 Jan: 39(1 Pt 1):95-103
7. Imhof M, Kühne U. A Phase ilI Study of in the Treatment of Glabellar Frown Lines. 2011; 4(10):28-34
8. Prager W, et al. Onset, longevity, and patient satisfaction with for the treatment of glabellar frown lines: a single-arm, prospective clinical study. 2013;8:449-56
9. Rappi T, et al. Onset and Duration of Effect of and AbobotulinumtoxinA in the Treatment of Glabellar Frown Lines: A Randomized, Double Blind Study. 2013 Sep 24: 6:211-19.
bottom of page